23 February 2024
Antibodies | Issue Cover Papers in 2022–2023
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
1. “Applications of Antibody-Based Antigen Delivery Targeted to Dendritic Cells In Vivo”
by Jessica Bourque and Daniel Hawiger
Antibodies 2022, 11(1), 8; https://doi.org/10.3390/antib11010008
Available online: https://www.mdpi.com/2073-4468/11/1/8

2. “Strategies to Screen Anti-AQP4 Antibodies from Yeast Surface Display Libraries”
by Aric Huang, Wei Jin, Ahmed S. Fahad, Brooklyn K. Mussman, Grazia Paola Nicchia, Bharat Madan, Matheus Oliveira de Souza, J. Daniel Griffin, Jeffrey L. Bennett, Antonio Frigeri et al.
Antibodies 2022, 11(2), 39; https://doi.org/10.3390/antib11020039
Available online: https://www.mdpi.com/2073-4468/11/2/39

3. “Mitochondrial Autoantibodies and the Role of Apoptosis in Pemphigus Vulgaris”
by Dana M. Hutchison, Anna-Marie Hosking, Ellen M. Hong and Sergei A. Grando
Antibodies 2022, 11(3), 55; https://doi.org/10.3390/antib11030055
Available online: https://www.mdpi.com/2073-4468/11/3/55

4. “Structural Investigation of Therapeutic Antibodies Using Hydroxyl Radical Protein Footprinting Methods”
by Corie Y. Ralston and Joshua S. Sharp
Antibodies 2022, 11(4), 71; https://doi.org/10.3390/antib11040071
Available online: https://www.mdpi.com/2073-4468/11/4/71

5. “Characterization of Active MMP9 in Chronic Inflammatory Diseases Using a Novel Anti-MMP9 Antibody”
by Maile Velasquez, Chris O’Sullivan, Robert Brockett, Amanda Mikels-Vigdal, Igor Mikaelian, Victoria Smith and Andrew E. Greenstein
Antibodies 2023, 12(1), 9; https://doi.org/10.3390/antib12010009
Available online: https://www.mdpi.com/2073-4468/12/1/9

6. “CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases”
by Sara Gómez-Melero and Javier Caballero-Villarraso
Antibodies 2023, 12(2), 30; https://doi.org/10.3390/antib12020030
Available online: https://www.mdpi.com/2073-4468/12/2/30

7. “Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy”
by Christopher Chung, Sagar B. Kudchodkar, Curtis N. Chung, Young K. Park, Ziyang Xu, Norbert Pardi, Mohamed Abdel-Mohsen and Kar Muthuman
Antibodies 2023, 12(3), 46; https://doi.org/10.3390/antib12030046
Available online: https://www.mdpi.com/2073-4468/12/3/46

8. “Antibody Cross-Reactivity in Serodiagnosis of Lyme Disease”
by Weronika Grąźlewska and Lucyna Holec-Gąsior
Antibodies 2023, 12(4), 63; https://doi.org/10.3390/antib12040063
Available online: https://www.mdpi.com/2073-4468/12/4/63
